SOHM Reports Consecutive Record Quarters With 1,000 Percent Year-Over-Year Revenue Increase for the Second Quarter 2010

BUENA PARK, CA–(Marketwire – August 26, 2010) –  SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that it has posted a 1,000 percent year-over-year increase in revenue for the second quarter ending June 30, 2010. Due to successive record quarters and the company’s unprecedented corporate revenue growth the Company expects continued consumer adoption of its private label generic pharmaceutical products. Revenues for the three months ended June 30, 2010 increased over 1,000% to $339,545 compared to $33,599 in the second quarter of 2009. Revenue growth was fueled by expansion of current and new clients and from pilot distribution projects to full production deployments.

Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc., stated, “Our ability to generate record revenue growth and accelerated consumer adoption rates for our generic pharmaceutical products is a direct reflection of our sales and marketing team’s dedication. We continue to demonstrate our ability to penetrate and lead in our chosen emerging markets. Most significantly, SOHM has grown and matured its generic drug manufacturing operations allowing for the scalability of resources and product production necessary to support a growing worldwide customer base.”

About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.